Nav: Home

Selective killing of cancer cells by cluttering their waste disposal system

March 16, 2020

A team of researchers from the Center for Soft and Living Matter, within the Institute of Basic Science (IBS, South Korea) and affiliated with Ulsan National Institute of Science and Technology (UNIST) has discovered a novel approach to selectively target and kill several types of cancer cells.

Lysosomes are small sacs filled with a large number of enzymes and acid that work to break down and recycle damaged and unwanted cellular components. In other words, they are simultaneously both a cell's waste container and recycling center. Typically, lysosomes get rid of the byproducts of this degradation process by releasing them outside the cell. Releasing the rubbish outside only makes sense. For example, imagine collecting all the rubbish in your house into a bin and then emptying that very same bin right on the floor in the kitchen, making your living conditions miserable. Similarly, puncturing the lysosomes and releasing their toxic contents inside the cell damages cellular components beyond repair which, in extreme cases, can trigger cell death.

Since cancer lysosomes are easier to damage than healthy cells' lysosomes, scientists have been looking into using this strategy as a promising alternative for targeting cancers that are resistant to conventional treatments. However, only a handful of potential therapeutics can target lysosomes, and most of them lack cancer selectivity.

Published in Nature Nanotechnology, this study shows that nanoparticles covered with a mixture of positively [+] and negatively [-] charged molecules can selectively kill cancer cells by targeting their lysosomes. The death of cancer cells results from a remarkable succession of transport and aggregation phenomena, starting with the formation of small nanoparticle clusters at cell surfaces and culminating with the assembly of micron-sized nanoparticle crystals inside the cancer lysosomes. Nanoparticle crystals induce lysosomal swelling, gradual loss of the integrity of lysosomal membranes, and finally cell death.

"In this work, we have harnessed the deregulated waste management system of the cancer cells to act as a "nanoscale assembly line" for constructing high-quality nanoparticle crystals that destroy the very lysosome "reactors" that allowed them to grow in the first place," says Bartosz A. Grzybowski, co-leading author of the study.

The aggregation of mixed-charge nanoparticles is favored by the acidic environment typical of cancer cells. "Non-cancerous cells, however, also internalize mixed-charge nanoparticles, but nanoparticle aggregation is limited. The nanoparticles quickly transit through the recycling routes and are cleared from these cells," explains Kristiana Kandere-Grzybowska, co-leading author of the study.

"Our conclusions are based on a comparison of thirteen different sarcomas, melanoma, breast and lung carcinoma cell lines with four non-cancer cell types," adds the first author of the study, Magdalena Borkowska. "The nanoparticles were effective against all thirteen cancer lines, while not harming non-cancerous cells."

The aggregation of the nanoparticles as they transit through the endolysosomal system of cancer cells is a complex process. The team discovered that nanoparticles with a surface composition of about 80% [+] and 20% [-] ligands show optimal cancer selectivity. The fact that negatively charged ligands are also pH-sensitive seems to be key to cancer selectivity. In the acidic pH, found around cancerous cells and inside the lysosomes, these ligands are protonated and prone to interact with similar ligands on the neighboring nanoparticles, thus promoting their aggregation. The balance between attractive interactions ? the bonds between [-] ligands and strong interactions between nanoparticle cores ? and electrostatic repulsions between [+] ligands on the neighboring particles determine the extent of nanoparticle aggregation. Overall, the interactions between particles, serum proteins and cells' internal environment work in concert to impair cancer lysosomes.

"The nanoparticle clusters may alter the lipid composition of the lysosome membrane, affect its integrity and render it less mechanically robust. Unexpectedly, our team also discovered that some proteins, such as the cell growth signaling molecules mTORC1, are displaced (and thus inhibited) from the surface of nanoparticle-containing cancer lysosomes. This is important because cancer cell growth and division require mTORC1, and nanoparticles are shutting it down only in cancer cells," explains Kandere-Grzybowska.

While single nanoparticles are approximately the same size as an average protein molecule, and thus too small to be seen with most dynamic live-cell microscopy approaches, the crystals composed of several nanoparticles can be observed. The team used a combination of complementary approaches, including dark-field microscopy, confocal reflection microscopy, and TEM, as well as biochemical and computational approaches to assess the full impact of mixed-charge nanoparticles on lysosomal organelles.

This study opens up new research directions. The mixed-charge strategy could be applied to other types of nanoparticles, such as polymer-based particles, dendrimers or iron oxide nanoparticles. Another important step will be testing the effectiveness of mixed-charge nanoparticles against tumors in animal models.
-end-


Institute for Basic Science

Related Cancer Cells Articles:

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.
Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.
First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.
Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.
Plant-derived SVC112 hits cancer stem cells, leaves healthy cells alone
Study shows Colorado drug SVC112 stops production of proteins that cancer stem cells need to survive and grow.
Changes in the metabolism of normal cells promotes the metastasis of ovarian cancer cells
A systematic examination of the tumor and the tissue surrounding it -- particularly normal cells in that tissue, called fibroblasts -- has revealed a new treatment target that could potentially prevent the rapid dissemination and poor prognosis associated with high-grade serous carcinoma (HGSC), a tumor type that primarily originates in the fallopian tubes or ovaries and spreads throughout the abdominal cavity.
The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.
White blood cells related to allergies may also be harnessed to destroy cancer cells
A new Tel Aviv University study finds that white blood cells which are responsible for chronic asthma and modern allergies may be used to eliminate malignant colon cancer cells.
Conversion of breast cancer cells into fat cells impedes the formation of metastases
An innovative combination therapy can force malignant breast cancer cells to turn into fat cells.
Breast cancer cells in mice tricked into turning into fat cells
As cancer cells respond to cues in their microenvironment, they can enter a highly plastic state in which they are susceptible to transdifferentiation into a different type of cell.
More Cancer Cells News and Cancer Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.